Inactive

REQUEST FOR INFORMATION ANNOUNCEMENT - COVID-19 Over The Counter (OTC) Self-Test Kits(Polymerase Chain Reaction (PCR) or/and Antigen tests) Defense Logistics Agency Troop Support SUMMARY The Defense L... REQUEST FOR INFORMATION ANNOUNCEMENT - COVID-19 Over The Counter (OTC) Self-Test Kits(Polymerase Chain Reaction (PCR) or/and Antigen tests) Defense Logistics Agency Troop Support SUMMARY The Defense Logistics Agency (DLA) Troop Support Medical Directorate is issuing a Request for Information (RFI), seeking manufacturer/distributor of various types of COVID-19 Over The Counter (OTC) Self-Test Kits(Polymerase Chain Reaction (PCR) or/and Antigen tests) to facilitate establishing a screening testing program for SARS-CoV-2, the virus that causes COVID-19, to test Federal employees and contractor employees who work onsite and who are not fully vaccinated or who have declined to provide their vaccination information. However, this initiative may be used to support other vulnerable populations. PROGRAM OVERVIEW DLA Troop Support is examining the potential to purchase an estimated 20 million tests over an eight (8) month period in support of the Safer Federal Workforce program. There is a potential requirement of an additional 30 million tests. However, these quantities and time period are subject to change as requirements are developed. The Safer Federal Workforce program is in accordance with Executive Order (EO) 13991, signed by President Biden on January 20, 2021; M-21-15 on COVID-19 Safe Federal Workplace: Agency Model Safety Principles, issued by the Office of Management and Budget (OMB) on January 24, 2021; M-21-25, on Integrating Planning for A Safe Increased Return of Federal Employees and Contractors to Physical Workplaces with Post-Reentry Personnel Policies and Work Environments, issued by OMB on June 10, 2021; and updated COVID-19 Workplace Safety: Agency Model Safety Principles, issued by the Safer Federal Workforce Task Force on July 29, 2021. The screening tests are intended to identify asymptomatic or pre-symptomatic infected individuals with or without known or suspected exposure to SARS-CoV-2.